Tenaya Therapeutics $52.5 million units offering
The units comprise common stock and warrants
Experience
To find Davis Polk deals and cases of particular interest, select filters based on practice, industry, region, lawyer and keyword.
Filters
Denali Therapeutics $400 million at-the-market offering
The shares are listed on the Nasdaq Global Select Market
Recursion Pharmaceuticals $500 million at-the-market offering
The shares are listed on the Nasdaq Global Select Market
CCC Intelligent Solutions Holdings $433.7 million secondary offering
The shares are listed on the Nasdaq Global Select Market
Life Time $699 million secondary offering
The shares are listed on the New York Stock Exchange
Haleon $3 billion secondary placing of ordinary shares
The private placement included 700,000,000 ordinary shares
Solid Biosciences $200 million stock and pre-funded warrants offering
The stock is listed on the Nasdaq Global Select Market
PPL $2 billion at-the-market offering
We advised PPL on the offering
InflaRx $30 million offering of ordinary shares and pre-funded warrants
The ordinary shares are listed on the Nasdaq Global Market
NeuroPace $74.75 million follow-on offering
The stock is listed on the Nasdaq Global Market